We performed a 125I accumulation study after lenvatinib treatment for thyroid cancer cells K1, FTC-133, and K1-NIS to investigate the effect of lenvatinib on intracellular radioiodine accumulation. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.